Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Post-osteoporotic fracture exercise program

Official title: Community Osteoporosis Exercise Class for People Post Fracture

Run by Western University, Canada · NCT07595991 · Data updated 2026-11-12

Aimed at people with osteoporosis who recently had a fracture, the study tests group exercise classes to see if they are feasible and safe and could help bone health and physical function.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorWestern University, Canada
Academic / other
Locations1 site (London, Ontario)
StatusRecruiting
StartedDecember 2026
Main results expectedAugust 2027
Study endsFebruary 2028
Registry record updatedNovember 10, 2026
Trial IDNCT07595991 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults diagnosed with osteoporosis who recently had a low-trauma fracture and are cleared for physical activity and English-speaking residents of the London, Ontario area.

Probably not a fit

Individuals not benefiting may be those who do not experience improvements in function or bone health, or who cannot safely participate due to medical or language barriers.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project enrolls adults with osteoporosis who have sustained a low-trauma fracture within the past year and are cleared for exercise. Participants will participate in group exercise sessions designed for osteoporosis, with safety and feasibility as primary concerns. The study will monitor adverse events, adherence, and changes in physical function to determine if such programs can be offered broadly as a non-drug option. The research is conducted at the Canadian Centre for Activity and Aging in London, Ontario, led by Western University. No comparator is specified, and the focus is on feasibility and safety in this high-risk population.

Why it matters

Potential benefit: If successful, participants may gain safer, structured opportunities to improve bone health and physical function, potentially reducing fracture risk.

How similar studies have gone: Previous research supports the feasibility and safety of exercise programs for osteoporosis, though the specific post-fracture, group-exercise format is relatively specialized.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosed with osteoporosis.
* History of low trauma fracture within the past year
* Cleared for physical activity using the get active questionnaire, 100 bpm resting heart rate or less, 160 mm Hg diastolic blood pressure or less
* Able to understand and provide informed consent.
* Residing within the study's geographic area (e.g., London, Ontario).

Exclusion Criteria:

* Individuals who do not understand the English language
* Medical conditions contraindicating participation in exercise (e.g., uncontrolled cardiovascular disease, severe respiratory illness).
* Cognitive impairments that prevent informed consent or participation.
* Recent major surgeries or medical events limiting physical activity.
* Participation in conflicting clinical trials or rehabilitation programs.
* Residents outside the designated study area.

Where it's running

  • Canadian Centre for Activity and Aging
    London, Ontario, Canada
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.